The pathological differential diagnosis of portal hypertension
Raouf E. Nakhleh – 29 September 2017
Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice
Jesse D. Riordan, Charlotte R. Feddersen, Barbara R. Tschida, Pauline J. Beckmann, Vincent W. Keng, Michael A. Linden, Khalid Amin, Christopher S. Stipp, David A. Largaespada, Adam J. Dupuy – 29 September 2017 – Most hepatocellular carcinomas (HCCs) develop in a chronically injured liver, yet the extent to which this microenvironment promotes neoplastic transformation or influences selective pressures for genetic drivers of HCC remains unclear. We sought to determine the impact of hepatic injury in an established mouse model of HCC induced by Sleeping Beauty transposon mutagenesis.
A porcine model for chronic hepatitis E
Ila Nimgaonkar, Alexander Ploss – 29 September 2017
Impact of hepatitis C virus eradication on hepatocellular carcinoma rates
Philippe J. Zamor, Mark W. Russo – 29 September 2017
Treatment of hepatitis C virus in advanced renal disease
Rajani Sharma, Robert S. Brown – 29 September 2017
Delta hepatitis: Toward improved diagnostics
Saleem Kamili, Jan Drobeniuc, Tonya Mixson‐Hayden, Maja Kodani – 29 September 2017
The pathological differential diagnosis of portal hypertension
Raouf E. Nakhleh – 29 September 2017
Chronic hepatitis C virus infection: Everyone should be treated
Steven Flamm – 29 September 2017
Chronic hepatitis C virus infection: Everyone should be treated
Steven Flamm – 29 September 2017
Impact of hepatitis C virus eradication on hepatocellular carcinoma rates
Philippe J. Zamor, Mark W. Russo – 29 September 2017